Biogen Inc.: Biogen and MedRhythms to Develop and Commercial

The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)MedRhythms to receive a $3 million upfront payment as

Related Keywords

Maine , United States , Cambridge , Cambridgeshire , United Kingdom , Morningside , North Lanarkshire , Brian Harris , Martin Dubuc , Walter Gilbert , Charles Weissmann , Heinz Schaller , Lauren Steidl , Ashleigh Koss , Mike Hencke , Elvir Mujanovic , Kenneth Murray , Exchange Commission , Youtube , Linkedin , Twitter , Head Of Biogen Digital Health , Facebook , Nasdaq , Rhythmic Auditory Stimulation , Biogen Digital , Chief Executive Officer , Sir Kenneth Murray , Nobel Prize , Healthy Lives , Breakthrough Device , Morningside Ventures , Private Securities Litigation Reform Act , Biogen , Medrhythms , Evelop , Ommercialize , Prescription , Digital , Herapeutic , Targeting , Treatment , Bait , Deficits , Multiple , Clerosis ,